Alan Barge
Director/Board Member at THERACRYF PLC
Profile
Alan Barge was the founder of ASLAN Pharmaceuticals Pte Ltd.
(founded in 2016) where he held the title of Senior Vice President-Oncology.
Currently, he is an Independent Non-Executive Director at Evgen Pharma Plc (since 2015), a Director at West Thorpe (2011) Ltd., a Director & Investor Director at Oribiotech Ltd., and a Venture Partner at Delin Ventures Ltd.
(since 2019).
In the past, he was the Chairman-Supervisory Board at Modra Pharmaceuticals BV, Global Medical Director-European at Amgen, Inc. (from 1990 to 1998), Vice President-Clinical & Head-Oncology at AstraZeneca PLC (from 2009 to 2010), and Chief Medical Officer at BerGenBio ASA (from 2018 to 2019).
Dr. Barge graduated from the University of Oxford in 1983.
Alan Barge active positions
| Companies | Position | Start |
|---|---|---|
| THERACRYF PLC | Director/Board Member | 2015-10-20 |
| West Thorpe (2011) Ltd. | Director/Board Member | - |
Oribiotech Ltd.
 Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Chief Investment Officer | - |
Delin Ventures Ltd.
 Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Private Equity Investor | 2019-02-28 |
Former positions of Alan Barge
| Companies | Position | End |
|---|---|---|
| BERGENBIO ASA | Chief Tech/Sci/R&D Officer | 2019-03-12 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 2010-11-30 |
| AMGEN INC. | Corporate Officer/Principal | 1998-08-31 |
Modra Pharmaceuticals BV
 Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands. | Chairman | - |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Founder | - |
Training of Alan Barge
| University of Oxford | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| THERACRYF PLC | Health Services |
| BERGENBIO ASA | Health Technology |
| Private companies | 5 |
|---|---|
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
| West Thorpe (2011) Ltd. | |
Modra Pharmaceuticals BV
Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Delin Ventures Ltd.
Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Finance |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Alan Barge
